New Elite Feature: Chart Templates — Your indicators and design everywhere on Finviz

Visionary Holdings Inc.

Contributing Author

Recent Articles by Visionary Holdings Inc.

Mar-26	Visionary Holdings Inc. (NASDAQ: GV) Enters into Strategic Cooperation Agreement to Expand Distribution Capabilities for Its V-Series Anti-Aging Products in China GV -6.81% GlobeNewswire
Mar-09	UPDATE - Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses GV -16.59% GlobeNewswire
Mar-05	Visionary Holdings (NASDAQ: GV) Provides 2026-2027 Growth Outlook; RAMU Anti-Aging Product Line Targets Potential $30 Million Annual Sales GV GlobeNewswire
Mar-02	Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses GV -5.13% GlobeNewswire
Feb-24	Visionary Holdings Announces Continued Progress of Approximately US$9 Million Sales Contract GV -9.32% GlobeNewswire
Feb-18	Visionary Holdings (Nasdaq: GV) Establishes Three Wholly Owned Subsidiaries in Qingdao, Wuxi and Wuhu, Advancing Commercial Expansion in China GV GlobeNewswire
Feb-13	Visionary Holdings Inc. Secures $450,000 in Debt Financing GV GlobeNewswire
Feb-04	Visionary Holdings Inc. Announces Resolution of Nasdaq Filing Deficiency and Confirmation of Continued Listing GV -8.40% GV GlobeNewswire
Feb-02	Visionary Holdings Inc. Regains Compliance with Nasdaq Periodic Filing Requirement GV GlobeNewswire
Jan-20	CORRECTION - Visionary Holdings Inc. Releases Final Fiscal Year 2025 Annual Report and Audited Financial Statements; Form 20-F Filing Pending GV GlobeNewswire
Jan-13	CORRECTION - Visionary Holdings Inc. GV +6.07% GlobeNewswire
Jan-12	Visionary Holdings Inc. Reports Fiscal Year 2025 Annual Report GV +21.87% GlobeNewswire
Dec-30	Visionary Holdings Inc. Announces Key Governance Updates, Strategic Pivot to High-End Medical Aesthetics, and Timeline for Annual Report Filing GV GlobeNewswire
Dec-30	Visionary Holdings (Nasdaq: GV) Appoints CEO of Health Technology Business, Establishes New Sales Entity in Nanjing to Accelerate Commercial Execution in China Market GV GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)